The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Critical Challenges in PD: Alpha-synuclein Neuroimaging, 2009Utility of the Amyloid Ligand [18F]FDDNP in Human PET Imaging in Parkinson Disease
Objective/Rationale:
Biomarkers of Parkinson disease are sorely needed for the assessment of disease status so that they may be used to design more efficient and informative clinical trials of disease... -
Critical Challenges in PD: Alpha-synuclein Neuroimaging, 200918F-labeled Alpha-Synuclein Ligands for PET Imaging of Lewy Bodies
Objective/Rationale:
The Avid-ProteoTech program aims at identifying radiopharmaceuticals for PET imaging of Lewy bodies in the human brain. Lewy bodies, formed by aggregates of alpha-synuclein, are a... -
Critical Challenges in PD: Alpha-synuclein Neuroimaging, 2008Generation of Alpha-Synuclein Conformation Specific Aptamers for In Vivo Bioimaging of Alpha-Synuclein Pathology
Objective/Rationale:
Alpha-synuclein is an abundant brain protein, whose misfolding has been associated to the development of Parkinson’s disease. Visualization of the different misfolded forms of... -
Critical Challenges in PD: Alpha-synuclein Neuroimaging, 2009A Strategy to Develop a Radiotracer Targeting Alpha-Synuclein
Objective/Rationale:
Alpha-synuclein is a protein that is found in nerve cells of patients with PD and therefore provides a potential target for methods designed to monitor the disease process in PD... -
Alpha-Synuclein Imaging, 2008In Vivo SPECT Imaging of Alpha-Synuclein Aggregation with Morphology Specific Antibody Based Ligands
Objective/Rationale:
The protein alpha-synuclein is a major constituent of the Lewy Body aggregates that are a hallmark feature of Parkinson’s disease and has been strongly correlated with the disease... -
Rapid Response Innovation Awards, 2009H5N1 Influenza Virus as a Etiological Agent in Parkinson's Disease
Objective/Rationale:
There is a significant literature (mostly based on cases from the Spanish Influenza outbreak of 1918) that has documented Parkinson’s disease occurring, following exposure to...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.